LSA
GH icon

Leonteq Securities AG’s Guardant Health GH Stock Holding History

Leonteq Securities AG’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$141K Sell
943
-317
-25% -$34.5K ﹤0.01% 635
2026
Q1 		$116K Sell
1,260
-809
-39% -$81.2K ﹤0.01% 698
2025
Q4 		$211K Buy
2,069
+41
+2% +$3.67K 0.01% 656
2025
Q3 		$127K Buy
2,028
+16
+0.8% +$870 ﹤0.01% 697
2025
Q2 		$105K Sell
2,012
-328
-14% -$14.7K ﹤0.01% 709
2025
Q1 		$99.6K Sell
2,340
-881
-27% -$38K 0.01% 701
2024
Q4 		$98.4K Sell
3,221
-4,348
-57% -$122K 0.01% 694
2024
Q3 		$174K Buy
7,569
+5,653
+295% +$160K 0.01% 523
2024
Q2 		$55.3K Sell
1,916
-6,329
-77% -$147K ﹤0.01% 744
2024
Q1 		$170K Buy
8,245
+2,649
+47% +$56.8K 0.01% 532
2023
Q4 		$151K Sell
5,596
-5,329
-49% -$140K 0.01% 556
2023
Q3 		$324K Buy
10,925
+6,566
+151% +$231K 0.02% 426
2023
Q2 		$156K Buy
4,359
+1,175
+37% +$33.7K 0.01% 585
2023
Q1 		$74.6K Buy
3,184
+1,166
+58% +$33.3K ﹤0.01% 699
2022
Q4 		$54.9K Buy
2,018
+710
+54% +$32.5K ﹤0.01% 806
2022
Q3 		$70.4K Sell
1,308
-132
-9% -$6.78K ﹤0.01% 727
2022
Q2 		$58.1K Sell
1,440
-1,299
-47% -$64.4K ﹤0.01% 799
2022
Q1 		$181K Sell
2,739
-791
-22% -$54.1K 0.01% 610
2021
Q4 		$353K Sell
3,530
-1,170
-25% -$121K 0.01% 517
2021
Q3 		$588K Buy
4,700
+1,679
+56% +$199K 0.03% 392
2021
Q2 		$375K Sell
3,021
-3,248
-52% -$437K 0.02% 444
2021
Q1 		$957K Sell
6,269
-1,016
-14% -$154K 0.06% 269
2020
Q4 		$939K Buy
+7,285
New +$838K 0.05% 292

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Leonteq Securities AG's GH Position: Q2 2026 in Review

Leonteq Securities AG reduced its Guardant Health (GH) stake by 25% in Q2 2026, selling an estimated $34.5K and leaving 943 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #635.

Leonteq Securities AG first reported a position in GH in Q4 2020 and has held it in 23 quarters since. The position peaked at $957K in Q1 2021. 595 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Leonteq Securities AG held 943 shares of Guardant Health worth $141K as of Q2 2026.
  • Leonteq Securities AG sold 317 Guardant Health shares in Q2 2026, an estimated $34.5K.
  • Guardant Health made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #635 holding.
  • Leonteq Securities AG first reported a position in Guardant Health in Q4 2020 and has held it in 23 quarters since.
  • Leonteq Securities AG's Guardant Health position peaked at $957K in Q1 2021.
  • 595 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.